Brigham and Women's Hospital: Venous Thromboembolism trials

The registry lists 12 Venous Thromboembolism studies with Brigham and Women's Hospital as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 4 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Statins to Prevent Cancer Associated Blood ClotsRecruitingNCT07303816Phase 4
• Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)RecruitingNCT03728166Not applicable
• Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous ThromboembolismCompletedNCT04168203Phase 4Results posted
• Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims DataCompletedNCT05264168
• Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims DataCompletedNCT04736719
• Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims DataCompletedNCT04736420
• Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims DataCompletedNCT04735523
• Improving Safety of Diagnosis and Therapy in the Inpatient SettingCompletedNCT04393909Not applicable
• Patient Safety Learning Laboratory: Making Acute Care More Patient-CenteredCompletedNCT02969343Not applicable
• Discharge ALERT: Quality Improvement InitiativeCompletedNCT00853463Not applicable
• Retrospective Study to Review Patients at Risk for VTE at Hospital DischargeCompletedNCT00604370
• Epidemiology of Venous ThromboembolismCompletedNCT00456196